Literature DB >> 31183547

Rapid differential diagnosis of vaginal infections using gold nanoparticles coated with specific antibodies.

Hossein Hashemi1, Jaleh Varshosaz2, Hossein Fazeli3, Seyedeh Maryam Sharafi4, Hossein Mirhendi1, Mostafa Chadeganipour1, HosseinAli Yousefi1, Kourosh Manoochehri5, Zahra Aliyari Chermahini5, Lobat Jafarzadeh6, Nafiseh Dehghanisamani6, Parvin Dehghan1, Hossein Yousofi Darani7.   

Abstract

Vaginal infections caused by bacteria, Candida and Trichomonas vaginalis, affect millions of women annually worldwide. Symptoms and signs have limited value in differential diagnosis of three causes of vaginitis. Current laboratory methods for differential diagnosis are either expensive or time consuming. Therefore, in this work, development of a method based on gold nanoparticles has been investigated for rapid diagnosis of vaginal infections. Specific antibodies against three main causes of vaginal infections were raised in rabbits. The antibodies were then purified and conjugated to gold nanoparticles and used in an agglutination test for detection of vaginal infections. Finally, sensitivity and specificity of this test for diagnosis of vaginal infections were estimated using culture method as gold standard. Purification of antibodies from sera was confirmed by electrophoresis. Construction of nanoparticles was proved by TEM and FT-IR methods. Conjugation of antibodies to gold nanoparticles was confirmed using XPS method. Sensitivity and specificity of gold nanoparticles for diagnosis of Candida species were 100%, for Gardnerella were 100% and 93%, and for T. vaginalis was 53.3% and 100%, respectively. Gold nanoparticle-based method is a simple, rapid, accurate, and cost-effective test for differential laboratory diagnosis of vaginal infections.

Entities:  

Keywords:  Antibody conjugated; Diagnosis; Gold nanoparticles; Vaginal infection

Mesh:

Substances:

Year:  2019        PMID: 31183547     DOI: 10.1007/s00430-019-00622-9

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  40 in total

1.  Interrelationships among human immunodeficiency virus type 1 infection, bacterial vaginosis, trichomoniasis, and the presence of yeasts.

Authors:  Prashini Moodley; Cathy Connolly; A Willem Sturm
Journal:  J Infect Dis       Date:  2001-12-04       Impact factor: 5.226

2.  The prevalence of trichomoniasis in young adults in the United States.

Authors:  William C Miller; Heidi Swygard; Marcia M Hobbs; Carol A Ford; Mark S Handcock; Martina Morris; John L Schmitz; Myron S Cohen; Kathleen Mullan Harris; J Richard Udry
Journal:  Sex Transm Dis       Date:  2005-10       Impact factor: 2.830

3.  Stability and electrostatics of mercaptoundecanoic acid-capped gold nanoparticles with varying counterion size.

Authors:  Timo Laaksonen; Päivi Ahonen; Christoffer Johans; Kyösti Kontturi
Journal:  Chemphyschem       Date:  2006-10-13       Impact factor: 3.102

Review 4.  Vaginitis: Diagnosis and Treatment.

Authors:  Heather L Paladine; Urmi A Desai
Journal:  Am Fam Physician       Date:  2018-03-01       Impact factor: 3.292

5.  Detection of trichomonosis in vaginal and urine specimens from women by culture and PCR.

Authors:  L F Lawing; S R Hedges; J R Schwebke
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

6.  Predictive value of the clinical diagnosis of lower genital tract infection in women.

Authors:  Daniel V Landers; Harold C Wiesenfeld; R Phillip Heine; Marijane A Krohn; Sharon L Hillier
Journal:  Am J Obstet Gynecol       Date:  2004-04       Impact factor: 8.661

7.  The importance of diagnostic work-up in the management of candidal vulvovaginitis. A prospective study.

Authors:  A Ben-Haroush; Y Yogev; B Kaplan
Journal:  Clin Exp Obstet Gynecol       Date:  2004       Impact factor: 0.146

8.  Comparison of nucleic acid amplification assays with BD affirm VPIII for diagnosis of vaginitis in symptomatic women.

Authors:  Charles P Cartwright; Bryndon D Lembke; Kalpana Ramachandran; Barbara A Body; Melinda B Nye; Charles A Rivers; Jane R Schwebke
Journal:  J Clin Microbiol       Date:  2013-08-28       Impact factor: 5.948

9.  Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000.

Authors:  Hillard Weinstock; Stuart Berman; Willard Cates
Journal:  Perspect Sex Reprod Health       Date:  2004 Jan-Feb

10.  Differentiation between women with vulvovaginal symptoms who are positive or negative for Candida species by culture.

Authors:  L M Linhares; S S Witkin; S D Miranda; A M Fonseca; J A Pinotti; W J Ledger
Journal:  Infect Dis Obstet Gynecol       Date:  2001
View more
  2 in total

1.  Myrtle-Functionalized Nanofibers Modulate Vaginal Cell Population Behavior While Counteracting Microbial Proliferation.

Authors:  Emanuela Bellu; Nicia Diaz; Martin Kralovič; Radek Divin; Giorgia Sarais; Angela Fadda; Rosanna Satta; Maria Antonia Montesu; Serenella Medici; Antonio Brunetti; Ana Rita Pinheiro Barcessat; Taťána Jarošíková; Jiří Rulc; Evzen Amler; Valentina Margarita; Paola Rappelli; Margherita Maioli
Journal:  Plants (Basel)       Date:  2022-06-15

2.  Anti-α4β7 monoclonal antibody-conjugated nanoparticles block integrin α4β7 on intravaginal T cells in rhesus macaques.

Authors:  Sidi Yang; Geraldine Arrode-Bruses; Ines Frank; Brooke Grasperge; James Blanchard; Agegnehu Gettie; Elena Martinelli; Emmanuel A Ho
Journal:  Sci Adv       Date:  2020-08-21       Impact factor: 14.136

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.